Jove
Visualize
Contact Us

Related Concept Videos

Molecular Models02:00

Molecular Models

43.6K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.6K
The Bohr Model02:18

The Bohr Model

80.4K
Following the work of Ernest Rutherford and his colleagues in the early twentieth century, the picture of atoms consisting of tiny dense nuclei surrounded by lighter and even tinier electrons continually moving about the nucleus was well established. This picture was called the planetary model since it pictured the atom as a miniature “solar system” with the electrons orbiting the nucleus like planets orbiting the sun. The simplest atom is hydrogen, consisting of a single proton as the...
80.4K
Stereotype Content Model02:16

Stereotype Content Model

15.4K
The Stereotype Content Model (SCM) was first proposed by Susan Fiske and her colleagues (Fiske, Cuddy, Glick & Xu, 2002; see also Fiske, 2012 and Fiske, 2017). The SCM specifies that when someone encounters a new group, they will stereotype them based on two metrics: warmth—or that group’s perceived intent, and how likely they are to provide help or inflict harm—and competence—or their ability to carry out that objective. Depending on the warmth-competence...
15.4K
Clearance Models: Physiological Models01:09

Clearance Models: Physiological Models

296
Drug clearance is a critical pharmacokinetic process involving the irreversible removal of drugs from the body through various organs over a specified time period. Physiological models are indispensable in determining organ-specific clearance, defined by the proportion of the drug eliminated per unit of time from the organ's blood volume.
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
296
Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

302
Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
302
Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

7.0K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A blueprint for local and distal invasion programs in glioblastoma.

Nature communications·2026
Same author

Opportunities to Modulate Tumor Ecosystem Toward Successful Glioblastoma Immunotherapy.

Cancer science·2025
Same author

Immunocompetent murine glioblastoma stem-like cell models exhibiting distinct phenotypes.

Neuro-oncology advances·2025
Same author

Glioblastoma Cortical Organoids Recapitulate Cell-State Heterogeneity and Intercellular Transfer.

Cancer discovery·2024
Same author

Defining heritability, plasticity, and transition dynamics of cellular phenotypes in somatic evolution.

Nature genetics·2024
Same author

BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling.

Proceedings of the National Academy of Sciences of the United States of America·2019
Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026
Same journal

Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.

Cancer research·2026
Same journal

Retraction: Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer.

Cancer research·2026
Same journal

Editor's Note: Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells.

Cancer research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 22, 2026

Molecular Evolution of the Tre Recombinase
12:02

Molecular Evolution of the Tre Recombinase

Published on: May 29, 2008

10.1K

Modeling Gliomas Using Two Recombinases.

Toshiro Hara1, Inder M Verma2

  • 1Laboratory of Genetics, Salk Institute for Biological Studies, La Jolla, California. thara@salk.edu THARA2@mgh.harvard.edu.

Cancer Research
|July 19, 2019
PubMed
Summary
This summary is machine-generated.

Researchers developed a new GFAP-FLPo mouse model for studying malignant gliomas. This model uses lentiviral vectors and FLP/FRT recombination for advanced glioma research and therapeutic development.

More Related Videos

Principles of Site-Specific Recombinase SSR Technology
07:06

Principles of Site-Specific Recombinase SSR Technology

Published on: May 29, 2008

21.5K
Author Spotlight: Patient-Informed 3D Model for Studying Glioblastoma Invasion via Interstitial Fluid Flow
04:30

Author Spotlight: Patient-Informed 3D Model for Studying Glioblastoma Invasion via Interstitial Fluid Flow

Published on: October 18, 2024

1.4K

Related Experiment Videos

Last Updated: Jan 22, 2026

Molecular Evolution of the Tre Recombinase
12:02

Molecular Evolution of the Tre Recombinase

Published on: May 29, 2008

10.1K
Principles of Site-Specific Recombinase SSR Technology
07:06

Principles of Site-Specific Recombinase SSR Technology

Published on: May 29, 2008

21.5K
Author Spotlight: Patient-Informed 3D Model for Studying Glioblastoma Invasion via Interstitial Fluid Flow
04:30

Author Spotlight: Patient-Informed 3D Model for Studying Glioblastoma Invasion via Interstitial Fluid Flow

Published on: October 18, 2024

1.4K

Area of Science:

  • Neuro-oncology
  • Genetics
  • Animal Models

Background:

  • Cre/loxP systems have advanced glioma research but limit further genetic manipulation.
  • Existing models face limitations in studying glioma progression after initial tumor induction.

Purpose of the Study:

  • To develop an adaptable mouse model for investigating glioma development.
  • To overcome limitations in studying glioma progression in existing models.

Main Methods:

  • Developed glial fibrillary acidic protein (GFAP)-FLP recombinase (FLPo) mice.
  • Utilized lentivirus-mediated in vivo delivery of cancer genes.
  • Employed FLP/FRT and Cre/loxP recombination systems for genetic manipulation.

Main Results:

  • Successfully initiated gliomas in GFAP-FLPo mice using lentiviral vectors and FLP/FRT recombination.
  • Demonstrated the model's utility in analyzing various stages of gliomagenesis via Cre-mediated systems.
  • Established a versatile platform for dissecting glioma developmental processes.

Conclusions:

  • The GFAP-FLPo mouse model offers expanded capabilities for glioma research.
  • This model facilitates the dissection of gliomagenesis and exploration of therapeutic strategies.
  • Presents a novel tool for advancing the understanding and treatment of malignant gliomas.